MultiOmic Health Raises £5M in Seed Funding Extension Round
The UK precision therapeutics discovery startup will use the new funding for a proof of concept in diabetic kidney disease.
Barcelona Supercomputing Center, Fujitsu Partner on Precision Medicine AI
The companies have entered into a research collaboration to develop AI that pulls insights from patients' genomic, health, and imaging data.
Predictive Oncology Shares Validation Data at AACR on Machine Learning Drug Development Platform
At AACR, the company shared data showing that its PeDAL platform could identify which tumors would respond to which drugs faster than traditional screening can.
DeepGlioma has shown it can classify brain tumors on the spot during surgery, and experts believe the AI-based imaging system can be useful for informing precision care.
M2Gen, Absci Team to Accelerate Precision Oncology Drug Discovery With AI
Drug development firm Absci will use M2Gen's ORIEN Avatar clinical and molecular dataset to match antigens to antibodies in pursuit of novel cancer biologics.